We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current GHRS market cap is 744.52M. The company's latest EPS is GBP -0.6840 and P/E is -20.94.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -9.72M | -17.16M | -11.53M | -13.22M | -12.62M |
| Net Income | -5.65M | -11.27M | -7.67M | -10.38M | -12.11M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -310k | -446k | -15.1M | -30.55M | -41.22M |
| Net Income | -310k | -446k | -9.2M | -22.46M | -35.59M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 232.57M | 226.3M | 217.58M | 206.98M | 199.61M |
| Total Liabilities | 6.8M | 7.33M | 7.84M | 8.3M | 10.25M |
| Total Equity | 225.77M | 218.97M | 209.75M | 198.68M | 189.37M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 504k | 5.91M | 279.92M | 254.36M | 226.3M |
| Total Liabilities | 104k | 246k | 2.75M | 4.55M | 7.33M |
| Total Equity | 400k | 5.67M | 277.18M | 249.82M | 218.97M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -25.25M | N/A | -9.6M | -19.53M | -31.84M |
| Investing | -54.08M | N/A | 8.79M | 28.52M | 43.8M |
| Financing | -163k | N/A | -71k | -185k | -245k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -289k | -330k | -15.28M | 165.96M | -33.34M |
| Investing | 797k | 5.5M | -104k | N/A | -54.1M |
| Financing | N/A | N/A | 286.45M | N/A | -204k |
| Market Cap | 744.52M |
| Price to Earnings Ratio | -20.94 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 9.5 |
| Price to Book Ratio | 3.4 |
| Dividend Yield | - |
| Shares Outstanding | 52.03M |
| Average Volume (1 week) | 344.91k |
| Average Volume (1 Month) | 1.17M |
| 52 Week Change | 76.67% |
| 52 Week High | 20.50 |
| 52 Week Low | 6.00 |
| Spread (Intraday) | 2.87 (19.29%) |
| Company Name | GH Research PLC |
| Address |
28 baggot street lower dublin D02 NX43 |
| Website | https://www.ghres.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
